Ranolazine as a novel therapy for pulmonary arterial hypertension.

Int J Cardiol

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China. Electronic address:

Published: November 2016

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.08.330DOI Listing

Publication Analysis

Top Keywords

ranolazine novel
4
novel therapy
4
therapy pulmonary
4
pulmonary arterial
4
arterial hypertension
4
ranolazine
1
therapy
1
pulmonary
1
arterial
1
hypertension
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!